A more recent study also localised ADAMTS12 in fibroblasts and macrophages located around CRC cells at the invasive margins and reported that low levels of ADAMTS12 in the stroma resulted in poor overall survival of CRC patients, supporting the hypothesis that stromal ADAMTS12 opposes tumour progression[79]. This evidence concerns the gene ADAMTS12 and neoplasm.